Augmentation Therapy Improves Survival in Patients with ɑ1 Antitrypsin Deficiency
According to recent research, augmentation therapy improves survival rates amongst patients with severe ɑ1 antitrypsin deficiency. The findings from this study may benefit those patients with AATD who experience a rapid decline in lung function.